Načítá se...
Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer
The identification of mutations in the epidermal growth factor receptor (EGFR) gene has revolutionized the treatment strategy for non-small cell lung cancer (NSCLC). The effectiveness of individualized treatment using EGFR tyrosine kinase inhibitors (TKIs) for EGFR-mutated NSCLC has mainly been clar...
Uloženo v:
| Vydáno v: | Proc Jpn Acad Ser B Phys Biol Sci |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Japan Academy
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443375/ https://ncbi.nlm.nih.gov/pubmed/32788550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2183/pjab.96.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|